YUHSpace

BROWSE

Export
0 549

Cited 14 times in

Cited 13 times in

Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC

DC Field Value Language
dc.contributor.authorLIM, SUN MIN-
dc.contributor.authorKim, Chang Gon-
dc.contributor.authorLee, Jii Bum-
dc.contributor.authorCho, Byoung Chul-
dc.date.accessioned2022-05-09T16:56:05Z-
dc.date.available2022-05-09T16:56:05Z-
dc.date.created2022-05-24-
dc.date.issued2022-01-
dc.identifier.issn2159-8274-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188288-
dc.description.abstractHER3 is ubiquitously expressed in EGFR -mutant non-small cell lung cancer (NSCLC) irrespective of resistant mechanisms to EGFR tyrosine kinase inhibitors, thus garnering attention as a valuable therapeutic target. In this issue of Cancer Discovery , Janne and colleagues highlight early clinical data supporting patritumab deruxtecan as a potentially appreciable agent for previously treated EGFR-mutant NSCLC.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Association for Cancer Research-
dc.relation.isPartOfCancer Discovery-
dc.relation.isPartOfCANCER DISCOVERY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePatritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorLIM, SUN MIN-
dc.contributor.googleauthorKim, Chang Gon-
dc.contributor.googleauthorLee, Jii Bum-
dc.contributor.googleauthorCho, Byoung Chul-
dc.identifier.doi10.1158/2159-8290.CD-21-1429-
dc.relation.journalcodeJ03328-
dc.identifier.eissn2159-8290-
dc.contributor.alternativeNameKim, Chang Gon-
dc.contributor.affiliatedAuthorLIM, SUN MIN-
dc.contributor.affiliatedAuthorKim, Chang Gon-
dc.contributor.affiliatedAuthorLee, Jii Bum-
dc.contributor.affiliatedAuthorCho, Byoung Chul-
dc.identifier.scopusid2-s2.0-85123567057-
dc.identifier.wosid000743249900001-
dc.citation.volume12-
dc.citation.number1-
dc.citation.startPage16-
dc.citation.endPage19-
dc.identifier.bibliographicCitationCancer Discovery, Vol.12(1) : 16-19, 2022-01-
dc.identifier.rimsid73987-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordPlusCELL LUNG-CANCER-
dc.type.docTypeEditorial Material-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalResearchAreaOncology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links